Alan Landay to HIV Antigens
This is a "connection" page, showing publications Alan Landay has written about HIV Antigens.
Connection Strength
0.584
-
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):163-71.
Score: 0.141
-
Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection. J Infect Dis. 1990 Nov; 162(5):1018-24.
Score: 0.098
-
Application of flow cytometry to the study of HIV infection. AIDS. 1990 Jun; 4(6):479-97.
Score: 0.095
-
Early immune senescence in HIV disease. Curr HIV/AIDS Rep. 2010 Feb; 7(1):4-10.
Score: 0.093
-
A look at HIV immune research. Interview by Alan Huff. Res Initiat Treat Action. 2000 Sep; 6(3):30-3.
Score: 0.048
-
Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS. 1996 Jun; 10(6):603-11.
Score: 0.036
-
Rapid rebound of serum human immunodeficiency virus antigen after discontinuing zidovudine therapy. J Infect Dis. 1988 Nov; 158(5):1132-3.
Score: 0.021
-
Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. JAMA. 1987 Sep 04; 258(9):1196-9.
Score: 0.020
-
Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons. AIDS Res Hum Retroviruses. 1999 Dec 10; 15(18):1713-5.
Score: 0.011
-
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis. 1998 Jul; 178(1):70-9.
Score: 0.010
-
Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine. JAMA. 1988 Nov 25; 260(20):3045-8.
Score: 0.005
-
HIV isolation from plasma of HIV-infected persons. N Engl J Med. 1987 Jun 11; 316(24):1547-8.
Score: 0.005